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The helper/inducer class of T lymphocytes has been recently divided into two
nonoverlapping subsets on the basis oftheir lymphokine secretion and requirement
for growth (1-3). Helper clones from the Thl subset produce IL-2 upon antigen
orlectin stimulation, whereas clones from theTh2 subset produce IL-4, alsoknown
as B cell stimulating factor 1 (BSF1).' Both subsets respond to IL-2, and both ex-
press, with minor quantitative differences, receptors for both lymphokines (4). But
antibodies directed against IL-2 inhibit only the antigen-stimulated growth ofThl
cells, whereasantibodies directed againstIL-4/BSF1 inhibit onlythe growth ofTh2
cells (4). To confirm this classification, we have used a novel approach, which allows
the specific inhibition ofthe biosynthesis ofeach respective lymphokine. Antisense
inhibition ofspecificprotein synthesis isachieved bysaturating the cellwith anucleotide
whose sequence is complementary to a portion of the mRNA encoding the protein
(5-10). The intracellular annealing ofthe complementary sequence to the message
prevents the synthesis ofthe protein. The complementary sequence can be intro-
duced intothe cell by transfection ofa plasmid in which the gene encoding the pro-
tein is in opposite orientation with respect to the promoter (6-10). In that case, an
intracellular excess ofantisense RNA is obtained, and an intracellular RNA/RNA
complex isformed. Alternatively, chemically synthesized short complementary DNA
sequence can be used (11-19). These synthetic oligonucleotides actively penetrate
into the cells, achieving relatively high intracellular levels (19). The advantage of
using such a strategy for lymphocytes is that, besides the fact that the low efficiency
transfection step can be avoided, the resultant intracellularduplex is a DNA/RNA
hybrid. Such duplexes are substrates for an enzymatic activity, RNase H, which
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specifically degrades the RNA strand in aDNA/RNA duplex (20-22) . Therefore,
the efficiency of the inhibition is potentially enhanced .
In this study, we have used two synthetic oligonucleotides, complementary to the
5'end ofthemRNA coding formouse IL-2 and mouse IL-4 (BSF1) . These sequences
correspond to portions of the leader sequence of the molecules . Proliferation of cells
from a Thl clone (131.1) was inhibited by the IL2 antisense oligonucleotide, whereas
cells from a Th2 helper clone, 1310 (23), were only inhibited by the IL-4 antisense
oligonucleotide . The inhibition was reversed by addition of exogeneous lymphokine
in both cases . The inhibition was accompanied by a decrease in the steady-state level
of the corresponding lymphokine mRNA, suggesting a possible degradation of the
message through an RNase H like activity.
Materials and Methods
Cell Lines.
￿
The D1 .1 cell line (2) is a helperT cell from the Thl subset . It was maintained
in 10% FCS RPMI supplemented with logo glutamine and antibiotics (Gibco Laboratories,
Grand Island, NY) and 1% nonessential amino acids (Gibco Laboratories), and stimulated
weekly with 100 ug/ml ofrabbit IgG presented by irradiated (1,200 rad) BALB/c spleen cells
depleted of red cells by a short hypotonic shock . The D10.G4 .1 (13.10) (23) cell line is a helper
T cell from the Th2 subset . It was maintained in RPMI 10% FCS supplemented with 1%
glutamine and antibiotics and stimulated weekly with Conalbumin (100 ug/ml) and mitomycin
C-treated C3H/HeJ spleen cells .
Oligonucleotides .
￿
Oligonucleotides IL-2 antisense (5'-CTGCATGCTGTACAT3'), IL-4 an-
tisense (5'-GGGGTTGAGACCCAT3'), and IL-4 sense (5'-ATGGGTCTCAACCCC-3') were
synthesized on a multiple column DNA synthesizer (model 8700 ; Biosearch, San Rafael, CA)
purified on acrylamide/urea gels followed by electro-elution and several cycles ofeihanol precipi-
tation . Oligonucleotides were finally resuspended in PBS before use.
Proliferation Assays.
￿
Cells were seeded in microtiter plates in RPMI supplemented as indi-
cated above and with 1% FCS (65oC heat inactivated) and in the presence or absence of
various doses of oligonucleotides . After 2 h of incubation at 37°C, the stimulant was added
(100 Rg/ml of rabbit IgG plus irradiated APCs for D1 .1 ; 100 wg/ml Conalbumin plus mitomycin
C-treated APCs for 1310) or not for the control, and the concentration of serum was raised
to 5% . After a period of 3 d, cultures were washed with RPMI in order to avoid any nonspecific
inhibition due to the possible presence offree thymidine from degraded oligonucleotide (three
times in 250 pl followed by centrifugation for 3 min at 1,200 rpm) ; 1 ACi of [ 3H]thymidine
(6.7 Ci/mmol; New England Nuclear, Boston, MA) in 10 17o FCS RPMI was added in each
well and cultures were incubated overnight at 370C . Cultures were harvested on a Skatron
AS (Heggtopen, Norway) cell harvester and incorporated radioactivity was quantified by scin-
tillation counting . All assays were carried out in triplicate. For reversal experiments, 10 U/ml
ofhuman IL-2 (Cetus Corp ., Emeryville, CA), or 200U/ml of mouse IL-4(Immunex Corp .,
Seattle, WA), or up to 50% ofcrude D10 conditioned supernatant was added after the prein-
cubation with oligonucleotides .
Northern Analysis.
￿
Dl .l or D10.G2 cells (15 x 10 6 in 5 ml of 1% 65oC heat-inactivated
FCS/RPMI) were preincubated in the presence or absence of 5 uM antisense IL-2 or IL-4
oligonucleotide, respectively, for 2 h as described above . 10 ug/ml ofConA (131.1) or 10 ug/ml
ofCon A plus 1 U/ml of mouse rIL-1 (kind gift ofDr. W. Benjamin, Hoffmann-La Roche,
Inc., Nutley, NJ) (1310) was added and the serum concentration was raised to 5% . After an
overnight period of incubation, cells were harvested, washed once in PBS, and resuspended
in guanidium-isothyocyanate followed by purification ofRNA on a standard cesium chloride
gradient .
Equal amounts ofRNA (15 gg of total RNA) were denatured with 6% formaldehyde for
10 min at 55°C in 1 x MOPS (20mM morpholine propane sulfonic acid, pH 7 .1, 5 mM
sodium acetate, 1 mM EDTA) and 50°Jo deionized formamide (Fluka Chemical Co., Haup-
page, NY), quickly chilled on ice, and size fractionated on logo agarose gels containing 6%HAREL-BELLAN ET AL.
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formaldehyde. After soaking of gels in 20 x SSC (1 x SSC = 150 mM sodium chloride, 15
mM trisodium sodium citrate, pH 7), RNA was transferred onto nitrocellulose filters (BA
85 ; Schleicher & Schuell, Inc., Keene, NH) by capillary blotting in 20x SSC using standard
procedures (24). Filters were then baked 2 h under vacuo at 80°C.
All probes used in this study were purified inserts, isolated after appropriate restriction
on 1% low-melting-point agarose (Bethesda Research Laboratories, Bethesda, MD), 32p-
labeled to 2-5 x 108 cpm/gg by primer extension using the Polymeraid labeling kit (PLS)
and [32P]dCTP (3,000 Ci/mM ; Amersham Corp., Arlington Heights, IL), and was purified
on G50 columns (Boehringer Mannheim Biochemicals, Indianapolis, IN). The mouse IL-2
probe was a gift from Frank Lee (DNAX Inc., Palo Alto, CA). The mouse IL-4 probe was
a gift from K. Arai (DNAX, Palo Alto, CA). The mouse actin probe was a gift from Dr.
K. O'Connel, PRI, Frederick, MD; the ribosomal RNA probe was a gift from Dr. D. Rad-
zioch, PRI. Filters were soaked for 2-24 h in prehybridization buffer (5 x SSC, 50% forma-
mide, 1 x Denhardt's solution, 20 mM Tris, pH 7.4, 0.2 mg/ml salmon sperm DNA, 5%
dextran sulfate), and hybridized with 5-10 ng/ml of labeled probes in the same medium for
20-48 h at 42°C. Filters were washed several times in 2 x SSC, 0.1% SDS at room tempera-
ture, one to three times 15 min in 0.1 x SSC, 0.10 7o SDS at 50°C, and exposed to Kodak
XAR-5 films with Cronex lighting plus intensifying screens (Dupont Co., Wilmington, DE)
at -70°C for 3-48 h. For relative quantities of hybridized radioactive probe, autoradiographs
were scanned using a densitometer and the relative intensities of the bands were estimated
by weighing the densitometer profiles. Hybridized radioactive probe was then removed by
immersion of the nitrocellulose filters in boiling water. Filters were checked before use with
other probes.
Results
Specific Inhibition ofthe Proliferation of Thl or Th2 Cell Lines by IL-2 orIL-4 Antisense
Oligonucleotides. Previous studies by our laboratory and others (16-19) have shown
that short oligonucleotides readily penetrate lymphoid or myeloid cells, reaching
significant levels within a few hours. Therefore, cells from the Dl.l clone, a murine
Thl helper clone (1) or from the D10 clone, a murine Th2 helper clone (23), were
preincubated for 2 h with various doses of anti-IL-2 or anti-IL-4 antisense oligonu-
cleotides, and activated with antigen and irradiated APCs. Proliferation was mea-
sured at day 3, using a thymidine incorporation assay as described in the Materials
and Methods. 131.1 cell proliferation was inhibited by the anti-IL-2 antisense oligo-
nucleotide, whereas D10 cells were inhibited by the anti-IL-4 oligonucleotide (Fig.
1). In both systems, a maximal inhibitory effect (90-100%) was reached between
5 and 10 pM of oligonucleotide. In both systems, the nonhomologous oligonucleo-
tide against the reciprocal interleukin did not have such an antiproliferative effect,
indicating that the inhibition was specific and not due to a toxicity of the oligonucle-
otides.
TheInhibition Can BeSpec
￿
allyReversed bytheAdditionofExogeneous Lymphokine.
￿
The
specificity of the inhibition was further assessed by reversal experiments. We rea-
soned that ifthe inhibition was due to the lack of lymphokine biosynthesis, the inhi-
bition should be reversed by the addition of exogenous IL-2 or IL-4. Therefore,
antisense-treated D1.1 or D10 cells were cultured in the presence or absence of ex-
ogeneously added IL-2 or IL-4, respectively. The results shown in Fig. 2 indicated
that exogeneous rIL2 was able to significantly reverse the proliferative blockade of
antisense IL-2-treated D1.1 cells, further demonstrating that the inhibition was specific
and not due to a toxic effect of the oligonucleotide. Similarly, exogeneously added
rIL-4 was able to overcome the inhibition of D10 proliferation by antisense IL-42312
￿
ANTISENSE OLIGONUCLEOTIDES IN HELPER T CELL SUBSETS
a D1 .1
b D10
FIGURE 1.
￿
Inhibition ofTh clones prolifera-
tion by antisense oligonucleotides. 131.1 (a)or
D 10 (b) cells were incubated 2 h with indi-
cated doses of IL-2 or IL-4 antisense oligo-
nucleotides, activatedwith antigen plusAPCs,
and thymidine pulsed 3 d later. The figure
showstheresult of atypical experiment, and
threeto five independent experiments gave the
same results.
oligomer. However, inthecase ofthe 1310 cells, this reversal effect was observed only
in the low range ofoligonucleotide concentration. A partial reconstitution was also
observed when a crude supernatant from antigen-activated 1310 cells was used in-
stead ofrIL4 (datanot shown). This suggests that this lack ofcomplete reconstitu-
tionwasnotrelatedto anintracellular inductionby IL-4ofotherindispensablegrowth
factorsthat couldbe present inthecrude supernatant. Asense control oligonucleo-
tide did not have any effect on 1310 cell proliferation in the range ofdoses used for
the antisense (data not shown). It is likely that, at high doses, the antisense IL-4
oligonucleotide caused some.nonspecific inhibition. This is confirmed by the slight
nonspecific inhibition observed on D11 cells using the antisense IL-4 oligonucleo-
tide, and could be related to the sequence itself.
Treatment with theAntisense Oligonucleotides Results in ReducedSteady-State Level ofLym-
ßhokine11"Iessage. To gain insight into the mechanism by which the antisense oligo-
nucleotides inhibited the autocrine growth of DU and 1310 cells, we performed
Northern analysis of the steady-state levels of lymphokine messages in these cells.
131.1 or1310cellswere incubatedwith antisenseIL-2 orIL-4 oligonucleotides, respec-
tively, and activatedwith ConA (131.1)orConAplus IL-1 (1310). After an overnighta-
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FIGURE 2.
￿
Reversal of inhibition
by exogenouslymphokines. D1.1 (a)
or D10(b)cells were incubatedwith
or without IL-2 or IL-4 antisense
oligonucleotides as indicated, and
activatedwith antigen andAPCs in
the presence or absence, as indi-
cated, of exogenous lymphokine.
Cultures were thymidine pulsed 3
dlater. Thefigure shows the result
ofatypicalexperiment, andtwoto
three independent experiments
gave identical results.
period of culture, cellswere lysed andtotal RNAs were extractedand analyzed using
IL-2 and IL-4 cDNA probes (Fig. 3). The antisense IL-2-treated D1.1 cells did not
express detectable level of IL-2 message, when compared with untreated controls
similarly activatedwith ConAplus IL-1 . Conversely, the antisense IL-4-treated D10
cells showed a significantly decreased level of IL-4 message (fivefold decrease). No
IL-4 message was detected in any of the D1.1 RNA samples and no IL-2 message
was detected in any of the D10 RNA samples (data not shown). The decrease in
lymphokine message was specific, since the steady-state level of actin message was
not impaired by the treatmentwith oligonucleotides (Fig. 3). Furthermore, thelevel
of rRNA was also unchanged in these samples (data not shown).
Discussion
In procaryotic cells, specific blockade of the expression of a gene has been one
of the major tools to assess the function of its product, through the use of deletion
or thermosensitive mutants. In mammalian cells, the difficulty of deriving mutant
cell line has prompted the search for other means of specific gene product deletion.
A possible solution wasderived from the study of gene regulation in bacteria, where2314
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FIGURE 3 .
￿
The steady-state level of lymphokine mRNA is decreased in the
presence of antisense oligonucleotides . 131.1 (a) orD10 (b) cellswere incubated
with or without IL-2 or IL-4 antisense oligonucleotides as indicated, and
activated with ConA or ConA plus IL-1 as indicated. After an overnight
period ofculture, cells were washed andRNAs were extractedand purified .
RNAs were electrophoresed on denaturing agarose gels, blotted, and ana-
lyzed for the level of IL-2, IL-4, or actin mRNA, as indicated .
the expression of certain genes is regulated by naturally occurring complementary
RNAs : such antisenseRNAs are thought to hybridize with thenormal message and
therefore to block its recognition and processing by the translational apparatus of
the cell (reviewed in reference 5) .
Recent studies have shown that artificial introduction of antisense plasmids into
eukaryotic cells resulted in a specific inhibition of the expression of exogenous as
well as endogeneous cellular genes (6-10) . The caveats of this technique are that:
(a) One needs to be able to efficiently introduce exogenous DNA in the cells ; (b)
There is a general requirement to achieve a 100-fold excess of the antisense over
the endogeneous sense message; and (c) In the specific case of genes related to cell
proliferation, an inducible blockade is required . Inducible promoters such as the
dexamethasone-inducibleMMTV promoter, have been successfully used in mouse
fibroblasts for specific inhibition ofthecfosgene (10) . This promoter, however, cannot
be universally used, since dexamethasone is, by itself, inhibitory for growth ofmost
lymphoid cells. Alternatively, synthetic oligonucleotides complementary to viral genes
have been shown to prevent infection of cells by several viruses, without affecting
normal cell growth (11-15) . In addition, weandothers (16-19)have specifically deleted
the expression of c-myc gene in T lymphocytes or in myeloid cells . In the present
study, we demonstrate the successful use of this strategy for the selective deletion
of secretory proteins in lymphocytes.
Studies ofthe lymphokine production and requirement forgrowth of cloned helper
T cell have shown the existence of two subsets, the Thl and the Th2 subset . Using
antibodies directed against these two lymphokines, it has been demonstrated thatHAREL-BELLAN ET AL.
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the Thl type produces IL-2 and proliferates usingIL-2 as an autocrinefactor, whereas
the Th2 type helper clones produces IL-4 and not IL-2, and proliferates using IL-4
as an autocrine factor. The two subsets are not overlapping, the Thl type helper
clones being inhibited only by anti-IL-2 antibodies, whereas the Th2 type helper
clones are inhibited only by anti-IL-4 antibodies. We here confirm these observa-
tionswith theantisense strategy, usingcomplementary, or antisense, short oligodeox-
ynucleotides. We show that antisense directed against the IL-2 message was able
to inhibit only a Thl helper clone proliferation, whereas antisense directed against
the IL-4 message inhibited only cells from aTh2 clone. The inhibition was not due
to a toxic effect of the oligonucleotides, since no inhibition was observed with the
antisense IL-4 on IL-2-dependent T cells, and vice-versa.
Furthermore, the inhibition could be reversed by exogenous addition of thelym-
phokine, although in the case of the antisense IL-4 oligonucleotide at high doses,
the reversal was only partial. This could suggest an intracellular effect of the lym-
phokine that could not be reproduced by the addition of extracellular IL-4. It is
likely, however, that this partialreversal reflects a nonspecific inhibition by high doses
of antisense IL-4, which is not detected with the antisense IL-2, but has been ob-
served in various systems.
The antisense oligonucleotides were originally thought to act through a specific
inhibition ofmRNA translation, on the basis of the results of several in vitro studies
(25-28). However, it has recently been suggestedthat in certain systems, the protein
synthesis inhibition could in fact result from the degradation ofthe relevant mRNA
by an enzymatic activity known as RNAse H (22). RNAse H specifically degrades
the RNA strand in aDNA/RNA duplex. In this study, we show that the inhibition
of cell proliferation was accompanied by a lower steady-state level of the relevant
message in each cell line. It is not known, at this point, ifthis lowerlevel of message
results from atranscriptional or post-transcriptional event. It could be due to afeed-
back effect of the disappearance of the protein, as it has been shown with mutated
globin genes, for example (29). However, alikely hypothesis is that thelymphokine
messages are degraded by an RNase H-like activity.
This type of study, involving the actual and specific inhibition of a lymphokine,
could prove helpful in understandingthe respective role of each of the helper T cell
subsets in thedifferent immunological situations in which helper T cells are known
to be involved. Antibody-mediated inhibition of lymphokines often does not give
consistent results. Antibody inhibition relies on the fact that the antibody can in-
hibit the binding of the lymphokine to the cellular receptor. The inhibition there-
fore depends on the relative affinity of the antibody versus the physiological ligand
for thereceptor. Furthermore, no effect would be obtained on the potential intracel-
lular action of thelymphokine in the producingcell. The antisense oligonucleotide
strategy, which allows the inhibition of the actual biosynthesis of the lymphokine,
could overcome these difficulties. In addition, antisensing lymphokines could have
potential therapeutic applications in the case of autocrine cancer cells, as it is al-
ready envisioned in the case of viral disease (11-15).
Summary
T helper cells have recently been divided into two subsets. The Thl subset se-
cretes and responds to IL-2 in an autocrine manner. The Th2 subset upon mitogen2316
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or antigen stimulation releases IL-4. Here we describe a novel technology that al-
lowed us to confirm this distinction. We have used synthetic oligonucleotides com-
plementary to the 5' end of mouse IL-2 and IL-4 to specifically block the biosyn-
thesis ofIL-2 or IL-4 in two murine helper Tcell clones from theThl or Th2 subset.
We show that the antisense IL-2 oligonucleotide inhibited the proliferation of the
Thl clone and had no effect on the Th2clone. In parallel experiments, the antisense
IL-4 oligonucleotide blocked the proliferationof the Th2 clone andnot the prolifer-
ation of the Thl clone. The inhibition was significantly reversed in both cases by
the addition of the relevant lymphokine (IL-2 in the case of the Thl clone, IL-4
in the case of the Th2 clone) . Northern analysis, using cDNA probes specific for
the two lymphokines, showed a decrease in the steady-state levelof the relevant lym-
phokine mRNA, suggesting the specific degradation of the mRNA by an RNase
H-like enzymatic activity.
This strategy, which allows thespecific blockade ofthebiosynthesis ofalymphokine,
couldbe useful for future studies on the role of each T helper subset in physiological
immune responses.
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